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Due to an increasing of antibiotic resistance prevalence, several alternatives to antibiotics have 
been considered, including bacteriophages. This project investigates the potential of sex pilus-
specific phage MS2 to drive loss and horizontal transfer of virulence plasmids from E. coli. The 
study assessed new E. coli host range of phage MS2, determining the natural transfer rate of 
pHaemolysin, pColicin V and F plasmids, and investigating the impact of phage infection on the 
virulence plasmids. Phage MS2 could not infect or replicate on the E. coli strains assessed in this 
study. The horizontal transfer rate of the pHaemolysin and pColicin V plasmids was negligible. 
Expression of the F pili would be essential for phage susceptibility and bacterial conjugation. 
Therefore, it is essential to investigate level of the F pili expression within the virulence plasmids. 
In conclusion, there is a potential limitation in using F pilus-specific bacteriophage to drive loss 
of virulence plasmids and this we propose this is due to low level of F pili expression and phage 
susceptibility. 
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 Abbreviation list 
Amp Ampicillin 
cAMP cyclic Adenosine Monophosphate 
AMR Antimicrobial Resistance 
APEC Avian Pathogenic E. coli 
CF Colonisation Factor 
cGMP cyclic Guanosine Monophosphate 
ColV Colicin V 
DAEC Diffusely Adherent E. coli 
DNA Deoxyribonucleic Acid 
DW distilled water 
EAEC Enteroaggregative E. coli 
EAF Enteropathogenic E. coli Adherence factor 
EDTA Ethylenediaminetetraacetic Acid 
EHEC Enterohaemorrhagic E. coli 
EIEC Enteroinvasive E. coli 
EPEC Enteropathogenic E. coli 
ETEC Enterotoxigenic E. coli 
ExPEC     Extra-intestinal Pathogenic E. coli 
F plasmid, pilus (pili)     Fertility plasmid, pilus (pili) 
GC-content Guanine-cytosine content 
Hly Haemolysin 
HC Haemorrhagic colitis 
HUS Haemolytic-Uremic Syndrome 
IS Insertion Sequence 
LB Luria-Bertani 
LEE Locus of Enterocyte Effacement 
LPS Lipopolysaccharide 
LT Heat-labile Enterotoxin 
MDR Multidrug-resistant 
MNEC      Meningitis-associated E. coli 
MOB Plasmid Mobility 
MOI Multiplicity of Infection 
MPF Mating Pair Formation 
NTEC     Necrotoxigenic E. coli 
ORF Open Reading Frame 
PAI Pathogenicity Island 
PBS Phosphate-buffered Saline 
PCR Polymerase Chain Reaction 
PFU Plaque Forming Unit 
PG Peptidoglycan 
R plasmid, factor    Resistance plasmid, factor 
Rif Rifampicin 
RNA Ribonucleic Acid 
RPBs Receptor Binding Proteins 
RTX Repeats in Toxin 
SBA Sheep Blood Agar 
SD Standard Deviation 
ST Heat-stable Enterotoxin 
STEC Shiga Toxin-producing E. coli 
UPEC Uropathogenic E. coli 
UTI Urinary Tract Infection 
VT Verotoxin 




1.1 Escherichia coli 
E. coli strains are commensal residents which reside in mucous layer of the mammalian colon and 
only cause disease in immunocompromised hosts or the hosts that gastrointestinal barriers are 
broken. Some strains have acquired specific virulence features, conferring increased ability to 
adapt to new niches and allowing them to cause a broad spectrum of disease (Kaper, Nataro, and 
Mobley 2004). Most of the virulence traits are encoded on mobile genetic elements that can be 
transferred between different strains or recombine into the genome, creating new combinations of 
virulence factors. The most successful combinations of virulence factors have persisted and led to 
specific pathotypes of E. coli, capable of causing disease in susceptible hosts as following; 
enteric/diarrhoeal disease, urinary tract infections (UTIs) and sepsis/meningitis. 
Virulent strains of E. coli can be categorised into those that cause intestinal or extra-intestinal 
infections (ExPEC) (Nataro and Kaper 1998). These pathogenic E. coli strains can be further 
classified into pathotypes based on their pathology and the presence of specific virulence plasmids 
(Table 1.1) (Kaper, Nataro, and Mobley 2004). There are 6 intestinal pathogenic strains; 
enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli 
(ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), and diffusely adherent 
E. coli (DAEC). Whereas, ExPEC strains consist of uropathogenic E. coli (UPEC), meningitis-
associated E. coli (MNEC) and avian pathogenic E. coli (APEC) which causes extra-intestinal 
infections – urinary tract and respiratory infections, pericarditis and septicaemia (Kaper, Nataro, 
and Mobley 2004; Nataro and Kaper 1998).  
EPEC, EHEC and ETEC can also cause disease in animals in a similar manner to human infections. 
With the exception of the intracellular pathogen EIEC pathogenic E. coli replicate extracellularly 
(Kaper, Nataro, and Mobley 2004). The E. coli pathotypes are further classified by their surface 
antigens, O (lipopolysaccharide, LPS) and H (flagellar), into serogroups (O antigen only) or 
serotypes (O and H antigens) (Neidhardt and Curtiss 1996; Nataro and Kaper 1998). 
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Table 1.1 Association of pathotype, disease and virulence-associated plasmid(s) modified from 
Johnson and Nolan 2009 and Kaper, Nataro, and Mobley 2004 
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adherence factors and 
toxins 
Enteroinvasive (EIEC) intestinal Watery diarrhoea, 


















extraintestinal UTI, sepsis, neonatal 
meningitis, or avian 
colibacillosis 






 aExPEC includes uropathogenic (UPEC), avian pathogenic (APEC) and meningitis-associated E. 
coli (MNEC). 
There is an increasing problem with antimicrobial resistance (AMR) E. coli in hospital settings. 
During 2012 to 2013, high percentages of multidrug-resistant (MDR) E. coli infections and death 
rates from bacteria resistance were reported (World Health Organization 2017). Underestimating 
the impact of AMR can cause a huge economic loss and contamination of AMR E. coli in livestock 
products can lead to E. coli-associated diseases in human (Russo and Johnson 2003; Lee et al. 
2009). This increase in AMR has led to the need for alternatives none antibiotic therapies or 
strategies to reduce AMR in bacteria. The alternatives such as probiotics, antimicrobial peptides, 
lysins and bacteriophages have been used not only to mitigate the AMR issue but also to target 
virulence factors of the bacteria which mostly encoded by plasmids (Ghosh et al. 2019). Using sex 
pilus-specific bacteriophages of E. coli to interfere with their plasmid-encoded virulence factors is 
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a promising method of interest to prevent pathogenic E. coli to transfer their pathogenic traits. 
Understanding plasmid biology and plasmids encoding virulence factors as well as sex pilus-
specific phages biology could be beneficial in investigating effects of the phages on E. coli 
virulence factors which are discussed below.   
1.2 Plasmid biology 
1.2.1 Plasmid classification 
Plasmids are self-replicating dsDNA episomal elements with their own origins of replication, 
being physically separated from the main chromosome (Clowes 1972; Watson 1987). They usually 
encode non-essential functions that are not affect the growth of bacteria so that neither their 
existence nor absence affect survival of the bacteria. Many plasmids are expendable; however, 
they provide unique functions to bacteria. Their copy number can differ from one plasmid to up to 
fifty per bacterium. This difference in copy number can be reflected in expression levels of  their 
protein products (Watson 1987).  
Plasmids can be classified based on several criteria such as host-tropism, features of replication 
and conjugation (mating pair formation; MPF), and plasmid mobility (MOB classification system) 
(Garcillan-Barcia, Alvarado, and de la Cruz 2011; Shintani, Sanchez, and Kimbara 2015; Smillie 
et al. 2010). There are two types of transmissible plasmids; conjugative and mobilizable plasmids. 
The conjugative plasmid contains the specific secretion system and coupling protein, conferring 
conjugation process. While, the mobilizable plasmid have an incomplete transfer system lacking 
the secretion system and sometimes the coupling protein and require co-expression of these genes 
from a conjugative plasmid to facilitate in plasmid transfer (Drlica and Gennaro 2001; Alvarado, 
Garcillan-Barcia, and de la Cruz 2012).  
Plasmid incompatibility classification is another method used to classify plasmids into 
incompatibility groups based on their replication control (Novick and Hoppensteadt 1978; Novick 
1987; Ishii, Hashimoto-Gotoh, and Matsubara 1978). Currently, there are 22 incompatibility 
groups of plasmids among the Enterobacteriaceae (Table 1.2) (Couturier et al. 1988; Carattoli et 
al. 2005; Carattoli 2009). Plasmids with the same replication control are incompatible, while 
plasmids with different replication controls are compatible (Couturier et al. 1988). Incompatible 
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plasmids cannot reside and maintain within the same bacterium or both be stably inherited in the 
absence of external selection because they share elements of their replication and partitioning 
systems. As a consequence, one of the two plasmids will be lost due to fluctuations in their copy 
numbers (Novick et al. 1976; Novick 1987). Incompatible plasmids can also exhibit entry 
exclusion which is a change on the surface of plasmid-containing cells in order to inhibit the 
transport of a related plasmid (Couturier et al. 1988).  
Incompatibility groups can be identified through PCR-based inc/rep typing method by using 
multiplex- and simplex-PCRs primer pairs to detect specific sites of each replicon such as iterons 
which encode replication initiation proteins, RNAI and repA genes (Carattoli et al. 2005; 
Konieczny et al. 2014). There are possibilities that one plasmid can carry multiple replicons and 
replicons can include various different loci which are not universal across plasmids. Therefore, 
MOB typing system is also applied to detect relaxase protein of the plasmid which is responsible 
for mobility and presented solely per plasmid (del Solar et al. 1998; Orlek et al. 2017).  
Table 1.2 Incompatibility groups and examples of plasmid and their species of origin (Carattoli 





Species of origin Plasmid function 
FIA F’ lac E. coli Fertility 
FIB F’ lac, ColV E. coli Fertility, Colicin V 
production 
FIC F’ lac, ColV E. coli Fertility, Colicin V 
production 
HI1 R27 S. Typhi Drug resistance Tc 
HI2 R478 S. marcescens Drug resistance 
CmKmTcHgTe 
I1 R483 E. coli Drug resistance 
SmSpTp 
Ig R621a S. Typhimurium Drug resistance Tc 




et al. 2000) 
N N3 Shigella spp. Drug resistance 
SmSpSuTcHg 
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P RP4 P. aeruginosa Drug resistance 
ApKmTc 
W pSa S. flexneri Drug resistance 
CmGmKmSmSpSuTm 
T Rts1 P. vulgaris Drug resistance Km 
A/C pIP40a P. aeruginosa Drug resistance 
ApKmSuHg 
K R387 S. flexneri Drug resistance CmSm 
B/O R16 E. coli Drug resistance 
ApSmSpSuTc 
X R6K  Drug resistance ApSm 
Y MIP231  Drug resistance Tc 




FII O157 E. coli O157:H7 Virulence factors 
production (Lim et al. 
2007) 
FIII ColB-K98 E. coli Colicin B and M 
production (Cooper 
and Rowbury 1986) 
FIV and variants R124 S. Typhimurium Drug resistance 
Abbreviations for drug resistance markers: Ak, amikacin; Ap, ampicillin; Km, kanamycin; Cm, 
chloramphenicol; Tc, tetracycline; Sm, streptomycin; Su, sulfonamides; Sp, spectinomycin; Gm, 
gentamycin; Hg, mercuric ions; Te, tellurium; Tp, trimethoprim; Tm, tobramycin 
1.2.2 Plasmid transfer mechanisms 
Plasmids can be transfer horizontally through main mechanisms; transformation and conjugation 
(Smillie et al. 2010). These mechanisms confer widespread transfer of genes concerning antibiotic 
resistance, metabolic functions and virulence determinants (Babic et al. 2008). Moreover, plasmids 
can integrate partially or completely of the bacterial genome into themselves by genetic 
recombination, increasing probability of genetic transfer (Brinton 1971).  
Transformation in the environment is a process where naturally competent bacteria can take up 
and incorporate linear, naked DNA. This then has the potential to recombine into their own 
chromosome (Watson 1987).  
Conjugation is a directed process of unidirectional transfer mediated by F plasmid from a F+ 
plasmids containing donor strain to recipient cell which do not carry F plasmid (F- cell) without 
wall-to-wall contact (Babic et al. 2008; Ou and Anderson 1970). The F- recipient cell converts into 
F+ donor cell by receiving a copy of F plasmid from its donor (Griffiths et al. 1999). Transfer of F 
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plasmid is mediated by the FinOP fertility inhibition system which the antisense RNA (FinP) and 
the RNA-binding protein (FinO) control the expression of TraJ, the transcription factor that 
upregulates the tra operon containing genes required for conjugation and plasmid transfer. FinO 
binds to FinP to protect the FinP from degradation and promote duplex formation of FinP and traJ 
mRNA, resulting in repression of traJ expression and conjugative F transfer (Gubbins et al. 2003). 
However, the F plasmid is normally de-repressed due to IS3 insertion within finO, causing 
mutation of the finO which gives rise to expression of tra operon (Cheah and Skurray 1986; Frost 
and Koraimann 2010). This confers high frequency transfer (HFT) phenotype for transconjugants 
to disseminate cargo genes such as antibiotic resistance and virulence determinants at high 
frequency. Whereas, other F-like plasmids in natural environment have a repressed phenotype with 
reduced mating efficiency (Frost and Koraimann 2010). The de-repressed resistance (R) factor, a 
F-like plasmid, can confer ability to conjugate on F- bacteria through F pilus production. Due to 
ability to inhibit F pili of the R factor, introduction of R factor into F+ cell can considerably reduce 
conjugation of the F+ strain by producing cytoplasmic repressor functioning on F pili, leading to 
loss of susceptibility to F-specific serum and F-specific phages (Ottow 1975). Genes within the F 
plasmid are responsible for mediating the contact between donor and recipient cells and regulation 
of DNA mobilization and unidirectional transfer. DNA transfer involves rolling circle replication, 
beginning with nicking of one strand of the F plasmid at oriT by the TraI protein, then the TraI 
becomes covalently bound to the 5’ end of the plasmid DNA. The plasmid is unwound by TraI 
and the nicked strand is transferred to the recipient cell (Drlica and Gennaro 2001). After the 
process is completed, transferred single-stranded DNA converted to double-stranded DNA by the 
synthesis of the complementary strand in the recipient cell in F’ transfer or incorporated into the 
recipient chromosome or degraded by RecBCD exonuclease (helicase/nuclease; enzyme 
degrading single- and double-stranded linear DNA) in Hfr transfer (Eggleston and West 1997; 
Kowalczykowski et al. 1994; Lloyd and Buckman 1995; Neidhardt and Curtiss 1996). The Hfr 
strain is attributed to the integration of F plasmid into the chromosome of the host cell after 
excision of F into F’ molecule carrying chromosomal genes with the conjugation genes which 
confer the chromosome genes to be mobilized and transferred to a recipient (Low 1991). Therefore, 
both Hfr and F’ transfers can serve as DNA vehicles in horizontal gene transfer between bacteria 
(Babic et al. 2008).  
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F plasmids contain 36 tra genes which encode the proteins required for conjugation, transfer and 
surface exclusion (Drlica and Gennaro 2001; Moore et al. 1987). These include ORFs for F pili 
(sex pili) which have an important role in single-stranded DNA transfer through conjugation by 
establishing contact between mating cells (Babic et al. 2008). The tips of the pili interact with the 
surface of cells lacking the F plasmid and then the F- cells are drawn to the F+ cells by 
depolymerisation (retraction) of the pili (Drlica and Gennaro 2001). A few theories of how DNA 
is transported through the F pili were proposed. First, DNA is believed to transported through the 
groove between the two rods of pili. Second, the F pili move resembling a conveyor belt while 
carrying DNA toward recipient. The last theory is that DNA bound to the F pilus, and then the F 
pilus moves toward recipient (Brinton 1971). Within the donor cell, the pili are double-stranded 
circular sex factor which can either replicate within the cell or contact with the recipient cell. Theirs 
active form is single strand for active transport to the recipient (Brinton 1971). Sex pili function to 
recognise recipient cell surfaces and conduct DNA transfer through cell-to-cell contact 
unidirectionally from the donor to its recipient. Normally, one donor cell can have 2-3 pili so it 
can attach to more than one recipient. Interaction between donors and recipients can be blocked 
through interaction of donor cell and F pilus-specific phage (Brinton 1971). 
1.2.3 Conjugative pili (F pili) 
Pili can be classified into 5 types based on functions and characteristics. The most common types 
are type I (common pili) and type II pili (conjugative or sex pili) (Brinton 1965; Ottow 1975). Sex 
pili originate from the donor membrane, they are assembled from F pilin molecule; phosphor-
glycoprotein, which controlled by traA, traQ and traX genes on the F plasmid which are 
responsible for F pilin formation and maturation (Ohtsubo 1968; Brinton, Gemski, and Carnahan 
1964; Frost, Ippen-Ihler, and Skurray 1994). TraA encodes the pilin, the pilus subunit of 
approximately 70 amino acids, while traQ encodes inner membrane protein which is necessary for 
pilin maturation. TraX, a highly conserved gene among F-like plasmids, encodes integral inner 
membrane protein with transmembrane domains responsible for acetylation at the N-terminus of 
F pilin (Frost, Ippen-Ihler, and Skurray 1994; Moore, Sowa, and Ippen-Ihler 1982; 
Maneewannakul, Maneewannakul, and Ippen-Ihler 1995). F pili grow rapidly and vertically from 
the cell surface up to one to two millimetres (Drlica and Gennaro 2001; Ottow 1975). The pili can 
detach from the cell by shearing which removes the ability to conjugate. However, F pili can return 
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to the normal number (ca. one per cell) and length within five minutes (Novotny et al. 1969; 
Novotny, Carnahan, and Brinton 1969; Brinton 1971). There are two forms of F pili; fibre and 
vesicle forms. Fibre form F pili assemble into rods that RNA pilus phage are adsorbed. Vesicle 
form F pili develop terminal knobs at one end of the F pilus, opposite to the site of RNA and DNA 
F pilus phage adsorption. The latest form rarely occurs but can be observed in F pili that had 
separated from donor cells and later re-adsorbed to donor cells by the distal ends with the vesicle 
on the proximal ends (Brinton 1971).    
F pili cannot be removed with the treatments that damage the cell membrane such as lysozyme or 
EDTA; therefore, donors retain their ability (Brinton 1971). However, The F+ cells are more 
susceptible to antibacterial agents such as sodium dodecyl sulphate, chloroform, lysozyme and 
tris-EDTA. This may be due to instability of the cell membrane in the presence of F pilin. 
Moreover, surface exclusion may occur when F pilin synthesis of one donor cell is interfered by 
another donor cell which finally leads to disappearance of F pili from the cell surface and loss of 
donor ability and pilus-specific phage sensitivity. Consequently, donors would become recipients 
(Brinton 1971). Besides, the presence of F pili also impairs flagellar function which requires 
membrane integrity. This gives rise to loss of motility of the F+ cells (Skaar, Richter, and Lederberg 
1957).  
1.3 Virulence plasmids of E. coli  
IncF plasmids were the first identified in enteric bacteria including E. coli, followed by the 
discovery of the colicinogenic (Col), antibiotic resistance (R) and virulence plasmids (Watson 
1987; Blum et al. 1995; Gyles 2004). Virulence plasmids of E. coli for the most part are self-
transmissible (Smillie et al. 2010; Gyles 2004) and the majority of virulence and antibiotic 
resistance (AMR) plasmids of E. coli are within the incompatibility group F (IncF) (Johnson and 
Nolan 2009; Kaper, Nataro, and Mobley 2004). However a number of virulence genes are found 
on incompatibility groups IncB/O (Kaper, Nataro, and Mobley 2004).  
This study focuses on virulence plasmids within the incompatibility group F, including colicin V, 
haemolysin, sex pili, capsular pilus antigen, and enterotoxin. However, only the colicin V and 
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haemolysin activities were observed in the experiment because they can be easily observed on agar 
plate.  
1.3.1 Colicin V 
Colicin V (ColV) was first described as a heat-labile product from E. coli V (Gratia 1925). ColV 
is a peptide antibiotic affecting the cytoplasmic membrane of closely related species susceptible 
cells but not on the bacteriocin-producing strain (Jacob et al. 1953; Yang and Konisky 1984). The 
ColV is encoded on the colicinogenic plasmid (pCol), belongs to incompatibility groups FIB, FIC 
and FIIA, of colicinogenic strains of E. coli (Smith and Huggins 1976; Couturier et al. 1988). ColV 
plasmids also contain an F transfer region and regions encoding plasmid maintenance and stability 
(Waters and Crosa 1991). Colicin has been referred to as bacteriocin, but has been grouped within 
the microcin class of antimicrobial polypeptides due to its small size and mechanism of synthesis 
which different from other colicins (Yang and Konisky 1984).  
Genes for ColV of E. coli are in an operon which includes cvaA, cvaB, cvaC, cvi and TolC 
(Neidhardt and Curtiss 1996; Johnson et al. 2006). The cva genes are responsible for ColV 
production, export and immunity. There are cvaA, B, C for colicin production and cvi for ColV 
immunity protein which protect the cell from ColV bactericidal activity by encoding cognate 
immunity proteins and transmembrane helicases that efficiently protect the cell from bactericidal 
activity of ColV (Gerard, Pradel, and Wu 2005). Whereas, the cvaA, cvaB and tolC genes are 
responsible for ColV export through an ABC exporter with a requirement of membrane integrity, 
the cvaC encodes the colicin (Gilson, Mahanty, and Kolter 1987; Gerard, Pradel, and Wu 2005). 
In addition, the chromosomally encoded, cvp, is required for ColV production; however its 
function is unknown (Fath, Mahanty, and Kolter 1989; Gerard, Pradel, and Wu 2005). 
Bactericidal activity of ColV is caused by disrupting of the membrane when ColV access to the 
inner membrane and attach to specific inner membrane receptor called the SdaC (DcrA) protein 
(Gerard, Pradel, and Wu 2005). Some studies revealed that the virulence phenotype conferred by 
ColV plasmid might resulted from other traits produced by the plasmid rather than the colicin V 
itself (Wick et al. 2005; Quackenbush and Falkow 1979). These include iron acquisition 
mechanisms and serum resistance. Iron acquisition was attributed to the presence of the aerobactin 
siderophore system, whereas; serum resistance was attributed to the presence of the iss and traT 
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genes which presented on ColV plasmids of APEC (Johnson et al. 2002). Apart from these two 
traits, ColV plasmid also have been associated with adherence, resistance to chlorine and 
disinfectants, growth in human urine, improved growth under acidic pH conditions, bacteriophage 
resistance, and the establishment of avian colibacillosis and murine septicaemia, meningitis and 
UTI (Hicks and Rowbury 1986; Aguero et al. 1989; Raja et al. 1991; Hu 1992; Provence and 
Curtiss 1994; Skyberg et al. 2006; Johnson and Nolan 2009).  
Another ColV-related plasmid is ColBM plasmids which have evolved from ColV plasmids and 
encode for colicins B and M, discovered in APEC strain and MDR E. coli strain (Johnson, Johnson, 
and Nolan 2006; Tivendale et al. 2009; Fricke et al. 2008). There were reports that ColV and 
ColBM plasmids have acquired MDR-encoding regions, conferring resistance to antimicrobial 
agents such as tetracycline, ampicillin, streptomycin, and trimethoprim (Fricke et al. 2009; Fricke 
et al. 2008). The linkage between MDR-encoding regions and ColV-encoded PAI is beneficial for 
selection of highly virulent strains through the use of antibiotics (Johnson and Nolan 2009). 
1.3.2 Haemolysin  
Haemolysin is a calcium dependent, pore forming cytolysin of the repeats in toxin (RTX)-family. 
The cytolytic activity of E. coli haemolysin is attributed to rapid formation of cation-selective 
channels in host cells, leading to osmotic lysis (Beutin et al. 1989; Welch 1991). There are two 
types of haemolysin; 𝛼-haemolysin and enterohaemolysin (Burgos and Beutin 2010). Haemolytic 
activity of 𝛼-haemolysin causes big clear zones of haemolysis after 4-6 hours of incubation (during 
growth phase) at 37˚C on standard blood agar plates (Beutin et al. 1990; Schmidt, Beutin, and 
Karch 1995). Whereas, enterohaemolysin is recognised by the appearance of small turbid zones of 
haemolysis without inner clear zone on blood agar plates with phosphate-buffered saline (PBS)-
washed erythrocytes after 18-24 hours of incubation at 37˚C (Beutin et al. 1989; Schmidt, Beutin, 
and Karch 1995). Both types of haemolysin are encoded by four genes within hlyCABD operon, 
found on either the chromosome or plasmid which bacteria can acquire through horizontal gene 
transfer. Conserve regions of the hlyCABD gene operon consist of regulatory gene (hlyR) located 
upstream of the operon and IS911 element located downstream of hlyD gene. The presence of IS-
elements flanking the plasmid-encoded 𝛼-hly indicate that they might be mobile genetic elements.  
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The plasmid-encoded 𝛼-hly, such as pEO5, pHly152 and pEO857, is associated with ETEC, STEC 
(Shiga toxin-producing E. coli) and EPEC strains. Whereas, 𝛼-haemolysin found in UPEC strains 
is encoded on chromosomal PAI I and II, such as strain O6:K15:H31 and O4:K6 found in human 
UPEC (Burgos and Beutin 2010; Burgos et al. 2009). Plasmid-inherited 𝛼-hly have evolved from 
one origin and independently from the chromosomally haemolysin operons because; 1) Regulatory 
region of hlyC of plasmid encoded 𝛼-hly genes were different from chromosomally inherited 𝛼-
hly and 2) The 5’ regulatory hlyR regions between chromosomally and plasmid-inherited 𝛼-hly 
operons are different that the chromosomally-encoded 𝛼-hly operons lack the hlyR and IS911 
elements (Burgos and Beutin 2010; Burgos et al. 2009). Alpha-haemolysin is synthesised as an 
inactive polypeptide and converted into active form by the HlyC protein, then secreted through the 
mediation of specific membrane translocator system encoded by hlyB and hlyD with the assist of 
outer membrane protein TolC (Schmidt, Beutin, and Karch 1995). The size of 𝛼-hly plasmids 
ranges from 48-157 kb. Not all the 𝛼-hly plasmid are conjugative, for example, pHly152 is a non-
conjugative plasmid found in murine E. coli strain, whereas pEO5 found in human EPEC is 
conjugative (Burgos et al. 2009; Hess, Pyper, and Clements 1986). Most of the 𝛼-hly plasmids 
have evolved from a common origin (Burgos and Beutin 2010).  
Another type of haemolysin is enterohaemolysin or EHEC-haemolysin which encoded on plasmid 
O157 (pO157) which is an F-like 92-kb plasmid within Inc group FIB and FII, found in EHEC 
strain such as E. coli O157:H7, O26 and O111. These strains are included in Shiga toxin-producing 
E. coli (STEC) that causes HC and HUS in humans (Carattoli et al. 2005; Johnson and Nolan 2009; 
Lim et al. 2007; Schmidt, Kernbach, and Karch 1996). The plasmid has the closest genomic 
sequence with the Yersinia pestis chromosome and plasmid, implying that pO157 was acquired 
from Y. pestis (Hinnebusch et al. 2002; Johnson and Nolan 2009). Enterohaemolysin is 
serologically and genetically different from 𝛼-haemolysin since a monoclonal antibody to E. coli 
𝛼-haemolysin does not bind to enterohaemolysin. In addition, DNA of enterohaemolysin-
producing E. coli does not hybridise with an 𝛼-haemolysin-specific gene probe (Beutin et al. 
1990). Biologically active enterohaemolysin was detected only in bacteria grown to the stationary 
phase and the haemolysin did not released into the culture medium (Beutin et al. 1990). Apart from 
Shiga toxins (Stx) and the locus of enterocyte effacement (LEE) pathogenicity island, the EHEC 
haemolysin is also responsible for the enterohaemolytic phenotype conferring adherence ability to 
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intestinal epithelial cells and long-term colonisation, and cellular damage of E. coli O157:H7 as 
well as survival in vivo and in the environment (Lim et al. 2007; Welch 1991). There are several 
other putative virulence factors encoded by pO157, including enterohaemolysin (ehxA), general 
secretory pathway (etpC to etpO), serine protease (espP), catalase-peroxidase (katP), a potential 
adhesion (toxB), a Cl esterase inhibitor (stcE) and attaching and effacing gene-positive conserved 
fragments (ecf) (Lim et al. 2007). Enterohaemolysin was found to be closely associated with 
verotoxin (Shiga-like toxin) production of verotoxin-producing E. coli (VTEC) strains in pigs and 
cows both healthy and with diarrhoea. Around 95% of the VT+ E. coli can produce 
enterohaemolysin, while only 5% of VT+ E. coli was found to produce plasmid-encoded 𝛼-
haemolysin (Beutin et al. 1989). 
1.3.3 Enterotoxin  
Enterotoxin is a plasmid-encoded virulence factor in ETEC strains causing self-limiting watery 
diarrhoea in human, and neotal and post-weaning pigs (Johnson and Nolan 2009). ETEC strains 
can produce either heat-labile enterotoxin (LT), heat-stable enterotoxin (ST), or both which most 
of the strains also express fimbrial adhesins known as colonisation factors (CFs). The plasmids 
encoding enterotoxin and CFs in human contain different regions of FII Inc group; replication, 
transfer and stability regions (Johnson and Nolan 2009; Gyles 2004). In porcine ETEC strains, 
genes encoding enterotoxins and CFs were found on separate plasmids and the plasmid encoding 
F18 CFs also contains haemolysin determinant and replicon of IncFII and IC (Fekete et al. 2002; 
Johnson and Nolan 2009). One plasmid, containing a PAI with a fragment of genes encoding STs 
known as pTC also contains tetracycline resistance (Fekete et al. 2003; Olasz et al. 2005). Some 
of the transfer regions are incomplete; therefore, the plasmids require other plasmids for 
mobilisation and co-transfer (Johnson and Nolan 2009; Reis et al. 1980).  
The LT is an immunogenic protein which is antigenically related to cholera toxin, affecting the 
adenylate cyclase system by deregulation. This results in over-production of cyclic adenosine 
monophosphate (cAMP), leading to opening of chloride channels in crypt cells and blockage of 
NaCl adsorption in apical tip cells which cause loss of water and electrolytes into the intestinal 
lumen, resulting in diarrhoea, hypovolemia and metabolic acidosis (Gyles 2004). There are two 
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serological subclasses of LT encoded on chromosome; 1) LT I, found in humans (LTh-I) and swine 
(LTp-I), 2) LT II (Hirsh and Zee 1999; Mainil 2013). 
The ST is non-immunogenic protein which affects the guanylate cyclase system within the cell by 
deregulating cGMP synthesis (Hirsh and Zee 1999). There are two types of ST; STa and STb. The 
STa can be encoded either by the genes located on plasmid or a transposable element (transposon), 
causing fluid and electrolyte accumulation in the intestines of suckling piglets by blockage of NaCl 
and water adsorption in tip cells, and loss of Cl ion at crypt cells. The STb is an uncommon 
plasmid-encoded toxin, causing fluid accumulation in piglets and weaned pigs (Hirsh and Zee 
1999; Mainil 2013).  
1.3.4 Capsular pilus antigen (K88) 
The K88 fimbriae or F4 antigen was first discovered in 1961 as the first colonization factor 
discovered on the cell surface of porcine ETEC strains, conferring ability to adhere to the epithelial 
mucosa of the small intestine and causing watery diarrhoea, dehydration and death in piglets (Nagy 
and Fekete 2005; Orskov et al. 1961; Fairbrother, Nadeau, and Gyles 2005; Jones and Rutter 1972). 
The adhesion is essential for the virulence of K88-containing bacteria by allowing the bacteria to 
attach to epithelium and overcome gut motility of the small intestine (Jones and Rutter 1972). 
Colonisation characteristics of the K88-positive and the K88-negative were not different. The K88-
positive strains were presented at the tissue surface, mostly adhere to the tips and the sides of villi, 
and epithelial mucous; however, absent from the intestinal lumen. Most of the K88-positive strains 
were present in posterior small intestine. While, some strains were located in anterior small 
intestine and in the middle of small intestine. These strains also produced K88 antigen in the large 
intestine but did not adhere to the epithelial surface of the large intestine or penetrate into the crypts 
of Lieberkühn. Unlike the K88-positive strains, the K88-negative strains were evenly distributed 
throughout the intestinal lumen and not attached to the tissue surface. Both K88-postive and K88-
negative strains cause clinical disease to piglets; however, severity of disease and mortality rate of 
the K88-negative strains were lower than those of the K88-positive strains (Jones and Rutter 1972). 
It was also associated with enteritis and oedema disease in swine (Nagy and Fekete 2005). In 
addition, there are other key virulence factors that have been implicated in ETEC causing 
postweaning diarrhoea such as haemolysins and F18 fimbriae (DebRoy and Maddox 2001). The 
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K88+ ETEC strains belong primarily to the O8, O45, O138, O141, O147, O149, and O157 
serogroups (Garcillan-Barcia, Francia, and de la Cruz 2009). 
K88 is encoded by a transmissible virulence plasmid (K88+ plasmid) which classified into three 
genetic variants based on antigenic regions, K88ab, K88ac and K88ad (Orskov and Orskov 1966; 
Fairbrother, Nadeau, and Gyles 2005). The K88ac is the most common variant among porcine 
ETEC strains (Fairbrother, Nadeau, and Gyles 2005; Nagy and Fekete 2005). The K88ab and 
K88ac operons appear to be located on a RepFIIA plasmid backbone. These variants bind to 
carbohydrates or glycoconjugants present on intestinal epithelial cells, intestinal mucus or red 
blood cells with different porcine cell preferences (Huisman et al. 1994). There are ten different 
genes for the operon encoding the K88, faeABCDEFGHIJ which divided into regulatory genes (a 
major subunit, FaeG and minor subunits, faeCFHIJ) and chaperone genes (faeDE), surrounded by 
insertion sequences which mediate virulence of the plasmid (Huisman et al. 1994). Many K88 
plasmid-containing isolates were found to have an F-type replicon and some possess conjugation 
systems resembled to those of the IncI1 incompatibility group, implicating the possibility that 
K88+ plasmids might belong to either the IncF or IncI1 group (Bradley 1985; Mainil et al. 1998). 
1.4 Use of alternatives to antibiotics to treat E. coli infection 
There are several approaches that have been implemented to prevent or delay AMR and to target 
virulence factors of the microbes using preventive and therapeutic measures. Vaccine is commonly 
used as preventive measure for bacterial infection. Since AMR has been increasing, the use of 
antibiotics is more restricted and must be used judiciously. Combination of antibiotics of different 
targets and recycling of antibiotics are also applied to delay the AMR (Gaur 2017). Therapeutic 
alternatives to antibiotics were categorised into naturally occurring, synthetic, and biotechnology-
based alternatives (Ghosh et al. 2019). Bacteriophages have been used as alternatives in forms of 
phage therapy and genetically modified phages. Another interesting strategy is bacterial virulence 
factor inhibitors which neutralise or inhibit expression of virulence factors through the uses of 
specific antibodies and liposome-based virulence inhibitor (Ghosh et al. 2019).  
Sex pilus-specific RNA bacteriophage, MS2, was found to reduce the carriage of AMR plasmids 
encoded by conjugative F-like plasmids by causing the loss of plasmids and blocking bacterial 
conjugation (Davis and Sinsheimer 1963; Colom et al. 2019). Several F-like plasmids also encode 
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virulence factors such as colicin V, enterohaemolysin, enterotoxin and fimbriae (Carattoli et al. 
2005; Couturier et al. 1988; Huisman et al. 1994; Johnson and Nolan 2009; Smith and Huggins 
1976). It is more likely that sex pilus-specific phage would affect expression and function of these 
virulence factors. Therefore, study of interaction between sex-pilus phage and its pathogenic hosts 
is essential for better insight of another alternative to antibiotics.  
1.5 Bacteriophage biology and applications 
MS2 bacteriophage was used in this study. This icosahedral lytic phage is within the genus 
Levivirus of the family Leviviridae. Its RNA contains approximately 3,500 nucleotides coding for 
maturation protein, coat protein, lysis protein and RNA replicase (Calendar 2006). Growth 
characteristics of MS2 phage include burst size of 10±1 PFU/cell and latent period of 60±2 minutes 
(Jain et al. 2006). More than 80 percent of the phage was adsorbed within different amount of 
times, ranging from 5 to 14 minutes (Davis and Sinsheimer 1963; Colom et al. 2019) 
There are two main genomic types of bacteriophages; DNA and RNA phages, either single-
stranded (ss) or double-stranded (ds). Moreover, bacteriophages can be classified by their 
morphology, including filamentous, icosahedral, tailed and pleomorphic (Abedon 2008; Calendar 
2006). Types of phage infection (Table 1.3) are determined by several criteria; bacterial survival, 
phage survival, phage genome replication, phage virion production, phage progeny release 
(Abedon 2008). Lytic phages reproduce within the bacterial hosts and kill the hosts by lysis, then 
their progeny is released from the damaged cells. Phages undergoing both lysogenic and lytic 
cycle, namely temperate phages, are less virulent than the lytic phages (Abedon 2008). 
Table 1.3 Stages of phage infection and mechanisms (Abedon 2008) 
Stages of phage infection  Mechanisms 
 
 
Lytic Bacterial host die from full reproduction of phages 
Lysogenic Non-productive stage, but phage genome can replicate or 
integrate into the host chromosome to produce the prophage 
which is inheritable 
Chronic Continuous phage production with the survived bacterial 
host 
Restriction Bacteria are immunized to infection or adsorbing phages 
Resistance Absence of irreversible adsorption, both phage and host 
survive 
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Process of phage infection initiates with attachment of phage to its host, followed by conformation 
changes of host cell membrane, and DNA injection into the host cytoplasm. Phages adsorb (attach) 
and infect their hosts through interaction between phage receptor-binding proteins (RPBs) and 
bacterial cell surface receptors, conferring binding specificity of phages and determining their 
bacterial host range. Gram-positive and -negative bacterial receptors can be either protein- or 
saccharide-based, including lipopolysaccharide (LPS), porins, peptidoglycan (PG), teichoic acids, 
pellicle layer, capsule, and protruding organelles (flagella, pilus) (Dunne et al. 2018; Nobrega et 
al. 2018). Tailed bacteriophages use their tail components such as tail fibres, tail spikes or tail tips 
to interact with host receptors (Nobrega et al. 2018). Whereas, some bacteriophages only adsorb 
to contractile pili such as pilus phages, including filamentous DNA phages and icosahedral single-
stranded RNA phages (Clarke et al. 2008; Rakhuba et al. 2010). Attachment of phages initiates 
with reversible when phage RPBs recognise bacterial receptors. Following this, the phage RPBs 
bind to bacterial outer membrane and the attachment becomes irreversible which induces opening 
of the phage connector and releasing of the genome into the bacterial cell (Kurtböke 2012). Single-
stranded phages such as MS2, a sex pilus-specific ssRNA phage, infect Gram-negative bacteria by 
using a maturation protein (Mat), presented on the phage capsid together with coat proteins, to 
attach to a pilus of the host. When ssRNA phages adsorbs to the side of a pilus, the binding process 
induces small orientational changes of the Mat related to the phage capsid. The presence of a 
network of hydrophobic and electrostatic interaction at the phage-pilus interface is detected. This 
results in priming of the Mat-connected genomic RNA (gRNA) to be releasing from the phage. 
After being released from the capsid, Mat-connected gRNA is taken up by the host through the 
retractile force of the host pilus (Clarke et al. 2008). Then, expression of the viral genes has 
initiated by cytosolic internalisation of the gRNA, resulting in replication, virion morphogenesis 
and lysis of the host (Chamakura and Young 2019; Meng et al. 2019).  
Bacterial hosts can develop resistance to phages. The MS2 phage infecting E. coli is capable of 
inducing phage-resistant mutants in the progeny of E. coli cells and selecting pre-existing phage-
resistant mutants from mutations in the region of the F-factor in the bacterial chromosome as a 
result of interaction between phage RNA with bacterial DNA. The interaction leads to loss of F-
pili and absence of RNA phage penetration into the host cell. MS2-induced mutants also exhibit 
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genetic instability and segregate new forms with new biochemical traits due to deletions of the 
region of the F-factor (Pererva, Miriuta, and Miriuta 2008).  
Bacteriophages have been applied in phage expression systems, phage display, pollution 
indicators, diagnostic systems and phage therapy. Phage-based expression systems have been used 
to engineer bacterial plasmids for molecular biology study. Phage display provides huge libraries 
of peptides or proteins for study of protein-target interaction. Phages have been used to detect 
enteric pathogens in water as indicator organisms. As bacteriophages have narrow host range, they 
have been used in diagnosing several pathogens that cause diseases in human such as Salmonella 
and Listeria. However, this application has not yet commercially succeeded due to development 
of phage resistance. Phages also have been used in treatment of infectious diseases as alternative 
antibacterial therapeutic agents to antibiotics (Calendar 2006).  
1.6 Aims  
The aim of this study was to explore the potential of sex pilus-specific phages to drive loss and 
transfer of virulence plasmids from E. coli. 
The key objectives were to: 
1. Assess existing pilus target phages for infection of virulence plasmid containing strains. 
2. To determine the natural transfer rate of the virulence (pHaemolysin and pColicin V) and 
F plasmids.  
3. To determine the impact of phage infection on the virulence plasmids. 
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2 Materials and methods 
2.1 Bacterial and bacteriophage strains  
Fifteen E. coli strains containing different plasmids were selected for this project (Table 2.1). 
Control strain E. coli K12/pFlac::Tn3, a lactose-fermenting strain containing F plasmid tagged 
with Tn3 (AmpR), was used as a host for MS2 bacteriophage replication (Colom et al. 2019; Davis, 
Sinsheimer, and Strauss 1961). Phage MS2, a ssRNA sex pilus-specific bacteriophage was used 
in this study. 
Table 2.1 E. coli strains used in the experiment 
E. coli strain Plasmid contained 
Proto/phly ampR Haemolysin, ampicillin resistance 
H209/phly Haemolysin 
H209 nalR Nalidixic acid resistance 
F157/pcolv Colicin V 
H247/pcolv Colicin V  
H247 Putative colicin V 
H209 Putative haemolysin 
Proto/phly Haemolysin 
K12 nalR Nalidixic acid resistance 
H209/phly Haemolysin 
K12/pcolv Colicin V 
711 nalR Nalidixic acid resistance 
P123/phly Haemolysin 
K12/pFlac::Tn3 Fertility tagged with ampicillin resistance 
J62 rifR Rifampicin resistance 
2.2 Growth and culture of bacteria 
All bacteria were preserved in 50% glycerol (1:1) and stored in -20˚C freezer until use. Luria-
Bertani (LB) broth and agar (Oxoid, UK) were used for routine growth and maintenance of 
bacteria. MacConkey agar (Oxoid, UK) was used to distinguish lactose-fermenting E. coli strains. 
To assess haemolysis, Sheep blood agar (SBA) was used. SBA was made by adding sheep blood 
at 5% v/v (Oxoid) in LB agar (Oxoid, UK). 
Top agar (overlay agar) was used for colicin V activity test and phage count. The agar was made 
of LB broth (Oxoid, UK) and 0.7% w/v of select agar (Oxoid, UK). The top agar was sterilised 
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and cooled to 50°C prior to adding bacteria for use as overlay for colicin V test and phage count. 
To assess colicin production, a colicin sensitive strain (E. coli K12 nalR) was used in an overlay 
agar with the ratio 1 : 0.1 (top agar : LB broth overnight culture), total volume of approximately 3 
ml for 99 mm Petri Dish. For phage count, phage sensitive E. coli strain K12/pFlac::Tn3 was used 
with the ratio 1 : 0.04 (top agar : LB broth overnight culture) of the total volume as same as the 
colicin V test. The top agar mixture was evenly poured on the 20-ml LB agar plate to make 
bacterial lawn and left to dry before adding samples.  
All media were made according to manufactures diluted with sterile distilled water (DW) and 
autoclaved. Sterile PBS (Sigma-Aldrich, UK) was prepared following manufactures instructions 
in  DW and sterilised by autoclave.  
2.3 Purified MS2 bacteriophage preparation 
Phage MS2 plaque formation and PFU assessments were assessed on E. coli strain 
K12/pFlac::Tn3.  To ensure that E. coli strain K12/pFlac::Tn3 was plasmid positive, the bacteria 
were recovered on MacConkey agar and incubated aerobically overnight at 37˚C. A single lactose-
fermenting colony was used to inoculate 10 ml LB broth and incubated aerobically overnight at 
37˚C prior to use.  
To culture phage MS2, 1 ml of overnight K12/pFlac::Tn3 was used to inoculate 9 ml of LB broth 
and 100 µl of MS2 phages from -20˚C were added. This was then incubated in a shaking incubator 
at 37˚C, overnight.  
To purify MS2, the overnight phage-E. coli culture was transferred to 25-ml Falcon tube and 
centrifuged 6,100 g for 15 minutes at room temperature (ca. 20˚C), the supernatant fluid was then 
filtered through 0.45 µm nylon filter to remove residual bacteria. Five hundred microlitres of 
purified MS2 phage was mixed with 500 µl of 50% glycerol to make a fresh glycerol stock and 
stored at -20˚C, while the remaining phages were stored at 4˚C and used as a working stock. 
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2.4 Phage count 
To quantify plaque forming unit per ml (pfu/ml), an overnight culture of E. coli strain 
K12/pFlac::Tn3 was used to prepare a bacterial overlay plate. Decimal dilutions of MS2 were 
prepared to 10-8 in PBS. Ten microlitres of each MS2 dilution were places on the top agar and 
allowed to dry in laminar flow cabinet. Plates were then incubated aerobically at 37˚C overnight. 
Finally, the number of plaques of the most disseminated and clear dilution factor was counted, and 





number of plaques = number of plaques of the most disseminated and clear dilution factor, dilution 
= dilution which the plaques are counted, volume of inoculated phage = 10 µl or 0.01 ml 
2.5 Haemolysin activity test 
E. coli strains were tested for haemolysin activity by streaking bacterial overnight LB broth culture 
on 5% v/v sheep blood agar and incubate in 37˚C incubator, overnight. Then, haemolysis zone 
were observed among the tested strains.  
2.6 Colicin V activity test 
E. coli strains were tested for colicin V activity by streaking or spotting single colony of each strain 
on LB agar plate topped with agar overlay of colicin V susceptible E. coli strain K12 nalR and 
incubated at 37˚C overnight. The plates were observed for clear zone around the colony indicating 
colicin V activity.  
2.7 Phage multiplication on selected E. coli strains 
Single colony of E. coli strains, including K12/pFlac::Tn3, picked up from LB and MacConkey 
agars, respectively, were inoculated into 10 ml of LB broth. Next, the overnight cultures in 10-ml 
LB broth were diluted at ratio 1:100 and incubated in shaking incubator at 37˚C for 2 to 3 hours to 
reach mid-exponential phase with bacterial concentration of approximately 107 cfu/ml. At the same 
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time, MS2 phage stock was diluted with sterile PBS to concentration 106 pfu/ml and then 100 µl 
dilute phage was transferred to the diluted LB broth cultures so that phage concentration will be 
105 pfu/ml. Before incubating in shaking incubator at 37˚C for 24 hours, phage count at 0 hour was 
performed by taking 1ml aliquot of each E. coli-phage mixture and filtering through 0.45 µm 
nylon. Then, the aliquot samples were diluted from dilution -1 to -4 with sterile PBS (ratio 1 : 9, 
total volume 200 µl). Negative control was also included by diluting MS2 phage 106 pfu/ml with 
10-ml LB broth to reach final concentration 105 pfu/ml. Top agar (20 ml) plates were prepared 
with 120-µl coli K12/pFlac::Tn3 and divided into 4-dilution compartments. After that, 10 µl of 
each diluted aliquot was dropped on Top agar according to their dilution factor from dilution -4 to 
-1, the plates were left to dry for a while and then transferred to 37˚C incubator and incubated 
overnight. Overnight LB broth culture of E. coli K12/pFlac::Tn3 was also prepared from a single 
lactose-fermenting colony with 10 ml of LB broth and incubated in shaking incubator at 37˚C for 
making bacterial overlay at 24-hour phage count the next day.   
Plates of phage count at 0 hour were observed for plaque number and calculated for pfu/ml. After 
24 hours of E. coli-phage mixture incubating, 1-ml aliquot of each mixture was taken and filtered 
through 0.45 µm nylon. Phage count at 24 hours was performed with the same process as the same 
as 0-hour phage count, the only exception is that the 24-hour aliquots were diluted from dilution -
1 to -8 and phage count was performed from dilution -3 to -8 pfu/ml was calculated by using the 
formula mentioned in section 2.4. 
If there were no plaque, use zero plaque calculation; 
pfu
ml
= lowest	dilution × 	number	of	plaque	 × 	factor	volume	for	aliquot	 
Lowest dilution = the most concentrated dilution of a particular plate, number of plaques = 1, factor 
volume =  incubated phage amount made up to 1 ml which is 10 µl plus 100 to make 1 ml 
2.8 Attachment of phage to selected E. coli strains 
All test strains were prepared in LB agar and aerobically incubated at 37˚C, also the E. coli 
K12/pFlac::Tn3 was prepared in MacConkey agar with the same conditions. A single colony of 
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each strain was picked up and inoculated in LB broth 10 ml and incubated in shaking incubator at 
37˚C overnight (12h). The overnight cultures were diluted at ratio 1:100 with 10-ml LB broth and 
incubated in shaking incubator at 37˚C for 2-3h. Then, MS2 phage stock was diluted with sterile 
PBS to reach final concentration 107 pfu/ml (MOI 0.1) by diluting phage stock from initial 






With the given MOI of 0.1, concentration of inoculated bacteria and phage was 107 cfu/ml and 108 
pfu/ml, respectively, then the inoculated phage volume would be 0.1 ml or 100 µl in 10-ml broth 
culture. After inoculating, the mixture was mixed by inversion 2-3 times. Negative control was 
also prepared by mixing 10 ml of sterile PBS and 100 µl of 108 pfu/ml phage and followed the 
same process as the tested strains. All tested mixtures and negative control were incubated in 
shaking incubator at 37˚C for 10 minutes, then 1 ml of each sample was taken up and filtered 
through 0.45 µm filter immediately. Overlay agar plates were prepared with K12/pFlac::Tn3. The 
plates were divided into 6 dilutions from -1 to -6. The filtered samples were diluted with sterile 
PBS from dilution -1 to -6 (20 µl of filtered sample: 180 µl of PBS), then 10 µl of each sample 
including negative control was dropped on Top agar plate according to their dilution and incubated 
in incubator at 37˚C, overnight. Finally, plaques were count and calculated for pfu/ml using the 
mentioned formulas above.  
2.9 Determining lactose, colicin V and haemolysin plasmids transfer rate 
This experiment was duplicated. The first attempt was achieved by static mating; whereas, the 
second attempt was done by filter mating to increased efficiency of conjugation. All donor strains 
and recipient strains were incubated overnight in 10-ml LB broth at 37˚C. Recipient and donor 
strains were inoculated into 10-ml of LB broth at ratio 5 : 1 and 1 : 1 for static mating (final volume 
60 µl) and filter mating (final volume 100 µl), respectively. 50-µl aliquots of recipient strain and 
10-µl of donor strain were inoculated into 10-ml of LB broth in static mating. A negative control 
was prepared with 50 µl of recipient alone in 10-ml LB broth. The mating mixture and control 
were incubated statically overnight at 37˚C for static mating. For filter mating, 100 µl 1 : 1 mixture 
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of donor and recipient were spread onto filter paper (Whatman, UK) and placed on LB agar plate 
and incubated statically overnight at 37˚C. After incubation the mating mixtures from static mating 
were diluted with LB broth from approximately 109 cfu/ml to 102 cfu/ml and 300 µl of diluted 
mating mixtures were plated on LB agar with antibiotic. Whereas, each incubated filter paper was 
transferred to a tube with 1-2 ml PBS and vortexed to remove bacteria from the paper, then diluted 
from dilution -1 to -6. The diluted samples were tested for single colony by dropping 10 µl of each 
dilution on LB agar with rifampicin 20 µg/ml. The dilutions giving single colony were then diluted 
with LB broth at ratio 1 : 9 and 300 µl of each diluted sample was spread on LB agar plate 
containing rifampicin 20 µg/ml. Except for K12/pFlac::Tn3, LB agar plates with 20 µg/ml 
rifampicin, 100 µg/ml ampicillin, and 20 µg/ml rifampicin with 100 µg/ml ampicillin were also 
applied for this strain. 
At least one hundred colonies were required for each strain to detect lactose fermentation, 
haemolysin and colicin V phenotypes. MacConkey agar, LB agar with K12 nalR, and 5% blood 
agar without antibiotic were prepared for lactose, colicin V and haemolysin plasmids detection, 
respectively. A plate was divided into at least 50 squares, so two plates were required to contain 
100 colonies for each sample. Following this, 100 colonies of each sample were picked and spot 
on particular agar according to the plasmid they carried, lactose plasmid-containing recipient was 
transferred to MacConkey agar, colicin V plasmid-containing recipient was transferred to LB agar 
with K12 nalR lawn, and haemolysin plasmid-containing recipient was transferred to blood agar. 
All plates were incubated at 37˚C overnight. Finally, lactose fermentation, colicin V and 
haemolysin activities were assessed.  
2.10 Plasmids preparation 
F, haemolysin, and colicin V plasmids were obtained for sequencing from E. coli K12/pFlac::Tn3, 
P123/phly, and H247/pcolv, respectively. QIAGEN Plasmid Midi kit (QIAGEN, UK) was used 
according to their sizes and copy numbers (Table 2.2), following the protocol for low-copy 
plasmids of 100 ml culture volumes to purify the plasmids (QIAGEN 2012). Agarose gel analysis 
was performed with the eluate products to determine the purification procedure that the products 
contain only plasmid DNA without contamination of other nucleic acids (Sigma-Aldrich, UK; 
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condition 95V, 90 minutes) (Sigma-Aldrich 2018). Plasmid DNA yields were also determined by 
NanoDrop™ (Thermofisher, UK) at 260 nm.  
Table 2.2 Sizes and copy numbers of F, ColV and haemolysin plasmids 
Plasmid name Size (kb) Copy number (copies) Reference 
F ca. 100 1-2 (Rosenberg and Hastings 2001) 
ColV ca. 40 1 (Cascales et al. 2007) 
pO157  92 3-4 (Lim et al. 2007; Noegel, Rdest, and 
Goebel 1981) 
2.11 Statistical analysis 
Descriptive statistic was used to analyse data obtained from the experiments.  
3 Results and discussion 
3.1 E. coli strain characteristics and MS2 phage count 
To confirm existence of the virulence plasmids in the E. coli strains used in this study, thirteen E. 
coli strains were tested for haemolysin and colicin V activities on specific agars. The selected 
strains contain none to maximum one plasmid. Six strains were haemolytic E. coli. Whereas, there 
are only three strains that were positive for colicin V activity (Table 3.1). Those that contained 
virulence plasmids will be subjected to experiment with phage MS2 to test whether the phage can 
eliminate virulence characteristics of the E. coli strains. 
Eight decimal dilutions of MS2 phage stock was count on susceptible bacterial lawn using overlay 
agar technique. The MS2 used in this study had concentration of 2.1*1011 pfu/ml. The stock was 
adjusted to optimal concentrations for each experiment.  
Table 3.1 Haemolysin and colicin V characteristics of E. coli strains 
E. coli strains Haemolysin Colicin V 
 
 
Proto/phly ampR + - 
H209/phly + - 
H209 nalR + - 
F157/pcolv - + 
H247 - - 
H209 - - 
Proto/phly + - 
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K12 nalR - - 
H209/phly + - 
H247/pcolv - + 
711 nalR - - 
K12/pcolv - + 
P123/phly + - 
 
 
+ = positive, - = negative 
3.2 Attachment of MS2 phage 
Phage attachment or adsorption experiment was accomplished to determine adsorption rate of the 
MS2 with E. coli strains in this study. Plaque forming unit per ml of free MS2 phage in supernatant 
after 10 minutes of incubation with tested E. coli strains decreased by 5 to 50 folds (average 11 
folds) from an initial concentration 107 pfu/ml to the range of 2*105 to 2*106 pfu/ml (Table 3.2, 
figure 3.1). The highest decreased pfu/ml was in E. coli proto/phly ampR. The lowest decreased 
pfu/ml was in K12/pFlac::Tn3. Whereas, the pfu/ml in negative control decreased by 10 folds. 
Decline in phage concentration in culture medium can be assumed as a result from phage 
attachment to the bacterial host. Percent of phage adsorption to host cell within 10 minutes was 
calculated using data obtained from the experiment, ranging between 10 and 24%. The highest and 
the lowest adsorption was in the strains proto/phly ampR and K12/pFlac::Tn3, respectively. The 
results contradicted to the facts that K12/pFlac::Tn3 was the susceptible host of MS2 phage and 
there should be no phage adsorption in negative control. However, the phage attachment 
experiment should be repeated because MS2 adsorption rate could not be determined from the 
preliminary experiment.  
 
Table 3.2 Pfu/ml of MS2 measured in culture medium after attachment period with tested E. coli 
strains and percent of phage adsorption from a preliminary experiment  
E. coli strains Phage count in 
supernatant (pfu/ml) 
Phage attached to host 
cell (pfu/ml) 




PBS control 1*106 1*101 14 
K12/pFlac::Tn3 2*106 5 10 
K12 nalR 1*106 1*101 14 
Proto/phly ampR 2*105 5*101 24 
Proto/phly 1*106 1*101 14 
H247 1*106 1*101 14 
F157/pcolv 1*106 1*101 14 
H209 9*105 1.11*101 15 
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H209/phly 4*105 2.5*101 20 
H209 nalR 4*105 2.5*101 20 
  
 
Figure 3.1 Changes in phage concentration in culture medium after 10-minute incubation of E. 
coli strains with the phage MS2, assuming MS2 attachment to the E. coli strains. Repeat of this 
experiment is suggested due to a decrease of the phage in negative control.   
 
3.3 MS2 host range 
Phage host range experiment was quadruplicated to determine susceptibility of the tested E. coli 
strains to the phage MS2. Data obtained from the first replicate was not completed and slightly 
different from others; therefore, only the data from replicate 2,3 and 4 was summarised using mean 
(SD). Phage multiplication in the susceptible host E. coli K12/pFlac::Tn3 increased within the 
range of 2*104 to 106 folds of average 1.03*105 folds. Whereas, multiplication of MS2 in tested E. 
coli strains increased by 1 to 1,300 folds with mean (SD) ranged between 1.78 (0.7) to 223 (191.01) 
(Table 3.3 and 3.4). Comparing with the E. coli K12/pFlac::Tn3, E. coli strains tested in this study 
were not likely to be susceptible to the MS2; however, the data was varied dramatically due to 
repression of the F pilus which complicate the results of this experiment. Further study should be 




Table 3.3 Multiplication in pfu/ml of MS2 after incubation with tested E. coli strains 
Number of 
replicates 
E. coli strains pfu/ml 







1 PBS control 3*106 - - 
K12/pFlac::Tn3 1*104 1*1010 106 
P123/phly <100 1*106 104 
H247/pcolv 2*105 1.3*106 1,300 
H209/pcolv 1*105 <1 0.001 
K12/pcolv 2*105 <1 0.001 
2 LB broth control 2*106 6*106 3 
K12/pFlac::Tn3 2*106 8*108 4*104 
P123/phly 3*106 2*107 6.67 
H247/pcolv 4*106 1*107 2.5 
H209/pcolv 4*106 2*107 5 
K12/pcolv 3*106 3*106 1 
3 LB broth control 1*106 1*106 1  
K12/pFlac::Tn3 1*106 2*1010 2*104  
P123/phly 6*105 2*107 33.33 
H247/pcolv 3*105 1*108 333.33 
H209/pcolv 2*106 2*106 1 
K12/pcolv 1.7*106 4*106 2.35  
4 LB broth control 1*105 1*105 1  
K12/pFlac::Tn3 2*105 5*1010 2.5*105  
P123/phly 1*104 2*106 200 
H247/pcolv 3*104 1*107 333.33 
H209/pcolv 1*104 <1 0.0001 




Table 3.4 Mean (SD) of number of phage increased in pfu/ml of different E. coli strains 
E. coli strains Mean (SD)  of increased pfu/ml 
 
 
K12/pFlac::Tn3 1.03*105 (1.3*105) 
P123/phly 80 (104.77) 
H247/pcolv 223 (191.01) 
H209/pcolv 2 (2.65) 
K12/pcolv 1.78 (0.7) 
 
 
3.4 Plasmid transfer rates 
Prior to experiment of using phage to inhibit virulence plasmid transfer, natural plasmid transfer 
rates of  pFlac::Tn3, pcolv and phly were determined comparing between two different methods; 
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static mating and filter mating. Transfer rates of haemolysin and colicin V plasmids were 0 to 8% 
and 0%, respectively. Whereas, transfer rate of F plasmid ranged from 10 to 97%, conferring high 
transmissible characteristic of the F plasmid (Table 3.5).  
Low natural transfer rate of the pcolv and phly may implicate experiment of phage effect on 
virulence plasmid transfer ; therefore, it is essential to scrutinise sequences and expressions of the 
virulence plasmids as well as of the F pili.  
Table 3.5 Transfer rate of F, haemolysin and colicin V plasmids of tested E. coli strains 
Donor strains recipient Antibiotic used Transfer rate  Static mating  Filter mating 
 
 
K12/pFlac::Tn3 J62 rifR Rif 20 µg/ml 60% 10% 
J62 rifR Rif 20 µg/ml 
and Amp 100 
µg/ml 
- 93% 
J62 rifR Amp 100 µg/ml - 97% 
P123/phly J62 rifR Rif 20 µg/ml 0% 1% 
H209/phly J62 rifR Rif 20 µg/ml 0% 8% 
H247/pcolv J62 rifR Rif 20 µg/ml 0% 0% 
K12/pcolv J62 rifR Rif 20 µg/ml 0% 0% 
 
 
Rif = rifampicin, Amp = ampicillin 
3.5 Plasmid preparation 
Due to low susceptibility of E. coli strains to MS2 phage, low transfer rate of the virulence 
plasmids and repression of the F pili, plasmid sequencing and mRNA expression level of the F 
pilus were planned to be accomplished to determine sequence and expression of the F pilus as well 
as incompatibility group of the three plasmids. To roughly determine plasmid sizes, prepare 
plasmids for sequencing and ensure purity of the products, all plasmids were purified and analysed 
with agarose gel electrophoresis and determined for DNA yield according to the low-copy 
plasmids preparation protocol. Concentrations of pFlac::Tn3, pcolv and phly were 150.4, 56.4 and 
73.74 ng/µl, respectively. Sizes of the three plasmids were beyond 1 kb (Figure 1.2) which were 
corresponded to those references mentioned in the Table 2.2. The plasmid products were sent for 
sequencing and will be subjected to alignment and analysed for mutations.  
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Figure 3.2 Agarose gel analysis of purified plasmids. Lanes are 
M = 1 kb plus ladder (Thermofisher, UK), PC = positive control; 
replicative M13 phage 7 kb, 1 = pFlac::Tn3, 2 = pcolv, 3 = phly 
(trimmed to remove non-project lanes) 
3.6 Discussion 
Due to COVID-19 pandemic, some experiments were put off and cannot be completed within the 
study period. This study was designed to examine virulence plasmid loss and reduction in 
frequency of conjugal transfer of virulence plasmids between E. coli strains through the use of sex 
pilus-specific bacteriophages. Bacteriophage susceptibility was assessed with E. coli strains 
harbouring certain virulence plasmids. Selected E. coli strains were characterised for 
bacteriophage susceptibility using the F pilus targeting phage MS2. Decreasing in the number of 
PFU in assays after 10-minute incubation is suggested the attachment of the phage to the E. coli 
strains but no replication. Comparing between E. coli strains with and without virulence plasmids, 
the E. coli strains containing non-virulence plasmids including the strains with AMR plasmids 
have phage attachment within the incubation period more than the strains with virulence plasmids 
and the phage susceptible strain. The K12/pFlac::Tn3 susceptible to phage MS2 have the phage 
attached by half of the K12 with AMR plasmid. The proto strain containing virulence and AMR 
plasmids has phage attachment by 5 fold of the strain containing only phly plasmid. Comparing 
among the H209 strains, the strain without plasmid has phage attachment far less than the strains 
containing virulence and AMR plasmids. The strains containing pcolv plasmid have an equal 
amount of phage attachment. However, comparing all tested strains with the phage MS2 
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susceptible strain, the susceptible strain has phage attachment less than all tested strains, 
suggesting that the incubation time is not sufficient or there were factors interfering with the 
attachment. Due to a decreasing in the number of plaques in the negative control, and slight 
attachment of the phage to its specific host, K12/pFlac::Tn3, this experiment should be repeated, 
and incubation time should be extended. The extension of incubation period and replicating of 
experiment would provide better insight of the phage attachment to the E. coli strains.  
Limited evidence of phage replication was observed between colicin V and haemolysin expressing 
E. coli strains, compared to the de-repressed MS2 host strain K12/pFlac::Tn3. There could be a 
reasons for this. The pili are not expressed or they are not receptive to MS2. Lack of expression of 
the F pili suggested repression of the transfer gene involving FinOP system, while lack of binding 
may be due to divergent sequences within the F pili producing genes (Frost and Paranchych 1988; 
Koraimann et al. 1996; Manchak, Anthony, and Frost 2002). Both these hypotheses would require 
further testing. Repression may be significant as the transfer rates for haemolytic and colicinogenic 
activity in this study are very low suggestive of a highly repressed transfer system. Repression of 
conjugative plasmid is probably to minimising the burden from either the host energy expended to 
maintain the conjugative apparatus or other associated properties such as pili-specific 
bacteriophage sensitivity (Ghigo 2001). However, the repressed conjugative plasmid can be 
temporarily de-repressed when the transconjugant acquires the plasmid, the newly transferred 
plasmid is transiently de-repressed until all the potential recipients have acquired the plasmid. 
Transitory de-repression often involves in biofilm formation to allow for horizontal plasmid 
transfer (Lundquist and Levin 1986). When plasmid transfer is completed, the conjugative pili 
recede and are replaced by adhesion factors such as other types of pili or exopolysaccharides in 
order to maintain the coherence of the biofilm (Ghigo 2001). In this work, phage infection was not 
assessed on biofilm forming bacteria so leading to a pilus repressed test population of bacteria. 
Therefore, one option to explore in further work would be to assess MS2 infection on model 
biofilms of these bacteria. This may be critical as expression during infection may be more akin to 
biofilms so F pilus may be de-repressed under infection conditions. 
We propose that a better approach would be to determine the sequence of pili and use this data to 
develop tools to show expression of pilin. Moreover, plasmid sequencing would provide 
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information on mutations of the pilin genes within the pFlac, pHaemolysin and pColicin V 
plasmids that may impact on phage binding. 
To determine mRNA expression levels of pilin from the plasmids in this study. We would 
determine the sequence for the traA gene responsible for F pilin production. Then design reverse 
transcriptase PCR primers to assess relative expression levels using SYBR green based qPCR. 
Pilin expression of the de-repressed pFlac pilin will be compared to pilin expression of the 
pHaemolysin and pColicin V plasmids. These expression levels will be standardised against tufA 
(encodes elongation factor Tu 1) and 16S RNA genes as controls. The proposed method will use 
primers specific to traA designed from sequence from our plasmids. Due to COVID-19 shut down 
this sequence was not obtained in time. Therefore, the traA nucleotide sequence from E. coli K12 
plasmid F (accession number MK492260.1) was used as a model for primer design using Primer-
Blast, NCBI. This uses a melting Tm of approximately 60°C and a GC-content of the primer pair 
is 55% (Table 3.6). The traA sequences of the pFlac, pHaemolysin and pColicin V plasmids would 
be subjected to the multiple sequence alignment program, Clustal Omega, (EMBL-EBI). This is 
to determine if homology is maintained across strains in this study. If there is significate sequence 
divergence then RT-primers would be designed individually for each plasmid. In addition to 
mRNA level of pilus, F Inc group typing can be determined from the sequence to confirm that the 
plasmids of the E. coli strains in this study are truly within the incompatibility group F.   
Table 3.6 Primer pair specific to traA gene 
Name Primer sequence Product size (bp) 
F_traA CGCCCGTCAAAAAGAAGTCG 282 R_traA CAAAACCGGCCAGGAACTTG 
The lack of conjugal transfer of the pColicin V plasmids in the colicinogenic E. coli strains 
suggested that the plasmids were completely repressed, resulting in no expression of the F pili. 
Low transfer rate of the pHaemolysin plasmids suggested partial plasmid repression or 
combination of repressed and de-repressed plasmids. Whereas, the pFlac plasmid was entirely de-
repressed, conferring the K12/pFlac::Tn3 an ability to transfer its plasmid to the recipient. Taken 
together with the minor replications of the phage MS2 observed among the haemolytic and 
colicinogenic E. coli strains, this low expression levels of the F pili of pHaemolysin and pColicin 
V plasmids may explain the lack of MS2 replication.  
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Another possible cause of MS2 resistance is mutations of the transfer genes which affect 
expression of the F pili. However, there is a possibility that the phage could not recognise the 
expressed F pili. As described above, expression of the F pili can be confirmed by detection of F 
pili mRNA level. The exact coding of the pilin can also be assessed from the primary plasmid 
sequence to determine any polymorphisms. Alternatively, both expression of pilus and attachment 
of the phage to the pilus can be achieved by using electron microscopy as previously shown for 
MS2 (Meyvisch, Teuchy, and Van Montagu 1974). 
Experiments on plasmid transfer rate in the presence of phage MS2 were planned to be 
accomplished in this study to determine the effects of the MS2 on virulence plasmid loss and 
horizontal virulence plasmid transfer. However, this could not be achieved due to the COVID-19 
shut down. We hypothesised that in the presence of F pili, MS2 phage could eliminate the virulence 
plasmids and reduce virulence plasmids transfer. However, the infection, replication and conjugal 
transfer data would suggest this may not succeed. 
Many research has been focused on using bacteriophage to target AMR and MDR bacteria, 
including reduction and prevention of AMR plasmids transfer, and AMR bacteria lysis (D'Accolti 
et al. 2019; Colom et al. 2019; D'Accolti et al. 2018). Although phage infection also contributed 
to transfer of AMR genes through transduction, the transduction rate was relatively lower than the 
conjugation rate (Volkova et al. 2014) This study is a novel aspect of using bacteriophage to 
mitigate the spread of virulence plasmids of virulent E. coli. Phages of several other pathogenic 
bacteria have been studied in reducing bacterial virulence as phage-based therapies. Some phage-
resistant mutant bacteria were found to be less or non-virulent and cause less severe disease in 
their host. The absence virulence factors may be essential for phage attachment (Heierson et al. 
1986; Laanto et al. 2012; Park et al. 2000; Santander and Robeson 2007). The phage-resistant 
bacteria can be beneficial for vaccine preparation against pathogenic bacteria as they lack of 
virulence factors but can modulate immune response and provide protection against pathogenic 
bacteria (Capparelli et al. 2010).  
In conclusion, there may be limitations on use of F pili specific phage to target virulence plasmids. 
Phage susceptibility depends on expression of the transfer genes; therefore, de-repression of the F 
pili in virulent E. coli strains would be central to success of this approach. There are clearly 
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limitations to our data that we lack full evidence of pilus expression and phage binding to the 
specific pili. In addition, the data do not reflect environmental expression during infection where 
use of these phage may be critical. 
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